NASDAQ: SLS · Health Care / Biotechnology: Pharmaceutical Preparations

SELLAS Life Sciences Group Inc.

How SELLAS Life Sciences Group Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.1B

Price

$10.15

P/E

-63.2

EPS (TTM)

$-0.16

1-year return

388.2%

Dividend yield

0.0%

52-week range

$1.46–$12.41

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources